Business Context and Reporting Period
Company: Harvard Bioscience, Inc. (HBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: March 10, 2021
Reporting Period: The filing announces financial results for the three and twelve months ended December 31, 2020.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific data regarding material changes versus prior periods. It only confirms the issuance of a press release containing these results.
Guidance, Outlook, and Management Commentary
Management Action: The Company issued a press release on March 10, 2021, and scheduled a conference call for 8:00 AM EST on the same date to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the periods ended December 31, 2020.
- Verify the details of the conference call held on March 10, 2021, for management commentary on the results.
- Confirm the trading symbol (HBIO) and exchange (NASDAQ) for current stock performance relative to the announcement.
- Note that the 8-K text explicitly disclaims the "filed" status of the financial results for liability purposes under Section 18 of the Exchange Act.